|
1
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vigneri R, Malandrino P and Vigneri P: The
changing epidemiology of thyroid cancer: Why is incidence
increasing? Curr Opin Oncol. 27:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qiu Z, Li H, Wang J and Sun C: miR-146a
and miR-146b in the diagnosis and prognosis of papillary thyroid
carcinoma. Oncol Rep. 38:2735–2740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Penha RCC, Sepe R, De Martino M, Esposito
F, Pellecchia S, Raia M, Del Vecchio L, Decaussin-Petrucci M, De
Vita G, Pinto LFR and Fusco A: Role of Dicer1 in thyroid cell
proliferation and differentiation. Cell Cycle. 16:2282–2289. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhuang J, Ye Y, Wang G, Ni J, He S, Hu C,
Xia W and Lv Z: MicroRNA-497 inhibits cellular proliferation,
migration and invasion of papillary thyroid cancer by directly
targeting AKT3. Mol Med Rep. 16:5815–5822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mahmoudian-Sani MR, Mehri-Ghahfarrokhi A,
Asadi-Samani M and Mobini GR: Serum miRNAs as biomarkers for the
diagnosis and prognosis of thyroid cancer: A comprehensive review
of the literature. Eur Thyroid J. 6:171–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boufraqech M, Klubo-Gwiezdzinska J and
Kebebew E: MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol
Metab. 30:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bai D, Sun H, Wang X, Lou H, Zhang J, Wang
X and Jiang L: MiR-150 inhibits cell growth in vitro and in vivo by
restraining the RAB11A/WNT/β-catenin pathway in thyroid cancer. Med
Sci Monit. 23:4885–4894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Yang H, Si Y, Hu D, Yu Y, Zhang Y,
Gao M and Zhang H: Iodine promotes tumorigenesis of thyroid cancer
by suppressing Mir-422a and Up-regulating MAPK1. Cell Physiol
Biochem. 43:1325–1336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paiva MM, Kimura ET and Coltri PP: miR18a
and miR19a recruit specific proteins for splicing in thyroid cancer
cells. Cancer Genomics Proteomics. 14:373–381. 2017.PubMed/NCBI
|
|
11
|
Small EM, O'Rourke JR, Moresi V,
Sutherland LB, McAnally J, Gerard RD, Richardson JA and Olson EN:
Regulation of PI3-kinase/Akt signaling by muscle-enriched
microRNA-486. Proc Natl Acad Sci USA. 107:4218–4223. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren C, Chen H, Han C, Fu D, Zhou L, Jin G,
Wang F, Wang D, Chen Y, Ma L, et al: miR-486-5p expression pattern
in esophageal squamous cell carcinoma, gastric cancer and its
prognostic value. Oncotarget. 7:15840–15853. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu J, Zeng Y, Xu C, Qin H, Lei Z, Shen D,
Liu Z and Huang JA: Expression profile analysis of microRNAs and
downregulated miR-486-5p and miR-30a-5p in non-small cell lung
cancer. Oncol Rep. 34:1779–1786. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Li M, Hu Y, Shi N, Yu H, Liu H and
Lian H: miR-486-5p attenuates tumor growth and lymphangiogenesis by
targeting neuropilin-2 in colorectal carcinoma. Onco Targets Ther.
9:2865–2871. 2016.PubMed/NCBI
|
|
15
|
Cao Z, Liu C, Xu J, You L, Wang C, Lou W,
Sun B, Miao Y, Liu X, Wang X, et al: Plasma microRNA panels to
diagnose pancreatic cancer: Results from a multicenter study.
Oncotarget. 7:41575–41583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li CY, Liang GY, Yao WZ, Sui J, Shen X,
Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Identification
and functional characterization of microRNAs reveal a potential
role in gastric cancer progression. Clin Transl Oncol. 19:162–172.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma X, Wei J, Zhang L, Deng D, Liu L, Mei
X, He X and Tian J: miR-486-5p inhibits cell growth of papillary
thyroid carcinoma by targeting fibrillin-1. Biomed Pharmacother.
80:220–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hutter C and Zenklusen JC: The cancer
genome atlas: Creating lasting value beyond its data. Cell.
173:283–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kolesnikov N, Hastings E, Keays M,
Melnichuk O, Tang YA, Williams E, Dylag M, Kurbatova N, Brandizi M,
Burdett T, et al: ArrayExpress update-simplifying data submissions.
Nucleic Acids Res. 43:(Database Issue). D1113–D1116. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chandran UR, Medvedeva OP, Barmada MM,
Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z,
et al: TCGA expedition: A data acquisition and management system
for TCGA data. PLos One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lassalle S, Zangari J, Popa A, Ilie M,
Hofman V, Long E, Patey M, Tissier F, Belléannée G, Trouette H, et
al: MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of
vandetanib. Oncotarget. 7:30461–30478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rossing M, Borup R, Henao R, Winther O,
Vikesaa J, Niazi O, Godballe C, Krogdahl A, Glud M, Hjort-Sørensen
C, et al: Down-regulation of microRNAs controlling tumourigenic
factors in follicular thyroid carcinoma. J Mol Endocrinol.
48:11–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maragkakis M, Vergoulis T, Alexiou P,
Reczko M, Plomaritou K, Gousis M, Kourtis K, Koziris N, Dalamagas T
and Hatzigeorgiou AG: DIANA-microT Web server upgrade supports Fly
and Worm miRNA target prediction and bibliographic miRNA to disease
association. Nucleic Acids Res. 39:W145–W148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C,
Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0:
Service integration into miRNA functional analysis workflows.
Nucleic Acids Res. 41:W169–W173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:(Database Issue). D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsang JS, Ebert MS and van Oudenaarden A:
Genome-wide dissection of microRNA functions and cotargeting
networks using gene set signatures. Mol Cell. 38:140–153. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:(Database Issue). D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vejnar CE, Blum M and Zdobnov EM: miRmap
web: Comprehensive microRNA target prediction online. Nucleic Acids
Res. 41:W165–W168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC,
Hsu PW, Wong YH, Chen YH, Chen GH and Huang HD: miRNAMap 2.0:
Genomic maps of microRNAs in metazoan genomes. Nucleic Acids Res.
36:(Database Issue). D165–D169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Blin K, Dieterich C, Wurmus R, Rajewsky N,
Landthaler M and Akalin A: DoRiNA 2.0-upgrading the doRiNA database
of RNA interactions in post-transcriptional regulation. Nucleic
Acids Res. 43:(Database Issue). D160–D167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weingarten-Gabbay S, Elias-Kirma S, Nir R,
Gritsenko AA, Stern-Ginossar N, Yakhini Z, Weinberger A and Segal
E: Comparative genetics. Systematic discovery of cap-independent
translation sequences in human and viral genomes. Science. 351:pii:
aad4939. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miranda KC, Huynh T, Tay Y, Ang YS, Tam
WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for
the identification of MicroRNA binding sites and their
corresponding heteroduplexes. Cell. 126:1203–1217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rehmsmeier M, Steffen P, Hochsmann M and
Giegerich R: Fast and effective prediction of microRNA/target
duplexes. RNA. 10:1507–1517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng Y, Chen L, Cao X, Ha S and Xie X:
Expression profiling and functional analysis of hsa-miR-125b and
its target genes in drug-resistant cell line of human gastric
cancer. Yi Chuan. 36:119–126. 2014.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
da Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uhlen M, Fagerberg L, Hallstrom BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai
Y, Xiao L, Huang S, Chen L, Guo Z, et al: MicroRNA-486 as a
biomarker for early diagnosis and recurrence of non-small cell lung
cancer. PLos One. 10:e01342202015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
He M, Wang G, Jiang L, Qiu C, Li B, Wang J
and Fu Y: miR-486 suppresses the development of osteosarcoma by
regulating PKC-δ pathway. Int J Oncol. 50:1590–1600. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang G, Liu Z, Cui G, Wang X and Yang Z:
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in
breast cancer cells. Tumour Biol. 35:11137–11145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Borjigin N, Ohno S, Wu W, Tanaka M, Suzuki
R, Fujita K, Takanashi M, Oikawa K, Goto T, Motoi T, et al:
TLS-CHOP represses miR-486 expression, inducing upregulation of a
metastasis regulator PAI-1 in human myxoid liposarcoma. Biochem
Biophys Res Commun. 427:355–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mees ST, Mardin WA, Sielker S, Willscher
E, Senninger N, Schleicher C, Colombo-Benkmann M and Haier J:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang LS, Li L, Li L, Chu S, Shiang KD, Li
M, Sun HY, Xu J, Xiao FJ, Sun G, et al: MicroRNA-486 regulates
normal erythropoiesis and enhances growth and modulates drug
response in CML progenitors. Blood. 125:1302–1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shaham L, Vendramini E, Ge Y, Goren Y,
Birger Y, Tijssen MR, McNulty M, Geron I, Schwartzman O, Goldberg
L, et al: MicroRNA-486-5p is an erythroid oncomiR of the myeloid
leukemias of Down syndrome. Blood. 125:1292–1301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ma X, Wei J, Zhang L, Deng D, Liu L, Mei
X, He X and Tian J: miR-486-5p inhibits cell growth of papillary
thyroid carcinoma by targeting fibrillin-1. Biomed Pharmacother.
80:220–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Borzi C, Calzolari L, Centonze G, Milione
M, Sozzi G and Fortunato O: mir-660-p53-mir-486 Network: A new key
regulatory pathway in lung tumorigenesis. Int J Mol Sci. 18:pii:
E222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan
IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al: Genomic loss
of miR-486 regulates tumor progression and the OLFM4 antiapoptotic
factor in gastric cancer. Clin Cancer Res. 17:2657–2667. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sun H, Cui C, Xiao F, Wang H, Xu J, Shi X,
Yang Y, Zhang Q, Zheng X, Yang X, et al: miR-486 regulates
metastasis and chemosensitivity in hepatocellular carcinoma by
targeting CLDN10 and CITRON. Hepatol Res. 45:1312–1322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Frietsch JJ, Kastner C, Grunewald TG,
Schweigel H, Nollau P, Ziermann J, Clement JH, La Rosée P, Hochhaus
A and Butt E: LASP1 is a novel BCR-ABL substrate and a
phosphorylation-dependent binding partner of CRKL in chronic
myeloid leukemia. Oncotarget. 5:5257–5271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang X, Lv W, Shi R, Cheng S, Zhang J and
Xu Z: The clinical implications of Crk-like adaptor protein
expression in papillary thyroid microcarcinoma. Tumour Biol.
35:12435–12440. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang J, Chen D, Liang S, Wang J, Liu C,
Nie C, Shan Z, Wang L, Fan Q and Wang F: miR-106b promotes cell
invasion and metastasis via PTEN mediated EMT in ESCC. Oncol Lett.
15:4619–4626. 2018.PubMed/NCBI
|
|
57
|
Gao ZJ, Yuan WD, Yuan JQ, Yuan K and Wang
Y: miR-486-5p functions as an oncogene by targeting PTEN in
non-small cell lung cancer. Pathol Res Pract. 214:700–705. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wu S, Wang J and Li F: Dysregulation of
PTEN caused by the underexpression of microRNA130b is associated
with the severity of lupus nephritis. Mol Med Rep. 17:7966–7972.
2018.PubMed/NCBI
|
|
59
|
Fang Z, Song R, Gong C, Zhang X, Ren G, Li
J, Chen Y, Qiu L, Mei L, Zhang R, et al: Ribonucleotide reductase
large subunit M1 plays a different role in the invasion and
metastasis of papillary thyroid carcinoma and undifferentiated
thyroid carcinoma. Tumour Biol. 37:3515–3526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhao Y, Liu X, Zhong L, He M, Chen S, Wang
T and Ma S: The combined use of miRNAs and mRNAs as biomarkers for
the diagnosis of papillary thyroid carcinoma. Int J Mol Med.
36:1097–1103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Geeves MA, Hitchcock-DeGregori SE and
Gunning PW: A systematic nomenclature for mammalian tropomyosin
isoforms. J Muscle Res Cell Motil. 36:147–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bastos AU, de Jesus AC and Cerutti JM:
ETV6-NTRK3 and STRN-ALK kinases fusions are recurrent events in
papillary thyroid cancer of adult population. Eur J Endocrinol.
178:85–93. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Iyama K, Matsuse M, Mitsutake N,
Rogounovitch T, Saenko V, Suzuki K, Ashizawa M, Ookouchi C, Suzuki
S, Mizunuma H, et al: Identification of three novel fusion
oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in thyroid
cancers of young patients in fukushima. Thyroid. 27:811–818. 2017.
View Article : Google Scholar : PubMed/NCBI
|
